Anyway, I suspect any takeover interest would wane considerably if NNZ2591 disappointed.
- Forums
- ASX - By Stock
- NEU
- $20 party
$20 party, page-44
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$16.23 |
Change
0.000(0.00%) |
Mkt cap ! $2.074B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 347 | $17.18 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.76 | 10 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 88 | 17.180 |
7 | 1492 | 17.040 |
3 | 987 | 17.020 |
4 | 608 | 16.980 |
2 | 49 | 16.860 |
Price($) | Vol. | No. |
---|---|---|
15.760 | 10 | 1 |
15.880 | 669 | 2 |
15.900 | 662 | 4 |
15.960 | 157 | 5 |
16.000 | 562 | 1 |
Last trade - 10.00am 13/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online